VELCERA
Velcera is a specialty pharmaceutical company with a passion for assuring pets receive the medicines they need to support excellent overall health. At Velcera, they are dedicated to developing innovative, high-quality products for the pet health market. They comply with the highest standards of practice through all phases, from development to manufacturing to marketing.
VELCERA
Industry:
Biotechnology Manufacturing Therapeutics
Founded:
2002-01-01
Address:
Yardley, Pennsylvania, United States
Country:
United States
Website Url:
http://www.velcera.com
Total Employee:
1+
Status:
Closed
Contact:
267-757-3600
Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon IPv6 Apple Mobile Web App Capable Microsoft Apple Mobile Web App Status Bar Style AWS Global Accelerator GoDaddy Shopify US Dollar Apple Pay
Similar Organizations
Balto Therapeutics
A specialty pharmaceutical company.
LipoSeuticals
Specialty pharmaceutical company.
Mylan Specialty
Engaged in the development, manufacture, and marketing of prescription drug products for the treatment of respiratory diseases.
PHARMAQ part of Zoetis
PHARMAQ is a pharmaceutical company.
SK biopharmaceuticals
Specialty Pharmaceutical Company
Founder
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Venture Round - Velcera
Official Site Inspections
http://www.velcera.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Velcera"
Powering Precision Medicine | Velsera
Transform medical and omics data into actionable insights with Velsera's precision medicine software platform. Accelerate R&D with data-driven solutions.See details»
Velsera - LinkedIn
Velsera connects healthcare and life sciences to reveal the true promise of precision medicine โ a continuous flow of knowledge between researchers, scientists, and clinicians around the world,...See details»
Velsera - Summa Equity
New Company, Velsera, Represents Summa Equity's โฆ
Jan 12, 2023ย ยท BOSTON & SAN FRANCISCO & STOCKHOLM-- (BUSINESS WIRE)--New company Velsera was announced today at the J.P. Morgan Healthcare Conference in San Francisco, California. The vision for Velsera is...See details»
Velcera - Crunchbase Company Profile & Funding
Velcera is a specialty pharmaceutical company with a passion for assuring pets receive the medicines they need to support excellent overall health. At Velcera, they are dedicated to developing innovative, high-quality products for the pet โฆSee details»
Newly Formed Velsera Seeks Additional Acquisitions to Build โฆ
Mar 7, 2023ย ยท NEW YORK โ Newly formed precision medicine technology firm Velsera, incorporated through a merger of Pierian, Seven Bridges Genomics, and UgenTec, is not yet โฆSee details»
Velcera, Inc. Company Profile | Omaha, NE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Velcera, Inc. of Omaha, NE. Get the latest business insights from Dun & Bradstreet.See details»
Velcera Management Team | Org Chart - RocketReach
Velcera is a private pet health company founded in 2004 focused on novel drug delivery systems (Promist) that make the administration of pet medications easier and more reliable. โฆSee details»
Pierian, Seven Bridges, UgenTec Acquired, Merged to Become โฆ
Jan 13, 2023ย ยท NEW YORK โ Healthcare and life science firms Pierian, Seven Bridges, and UgenTec have been acquired by investment fund Summa Equity for an undisclosed amount โฆSee details»
New company, Velsera, represents Summa Equityโs vision to โฆ
Jan 13, 2023ย ยท Today Velsera comprises three global, industry leading organizations in the healthcare and life science industries: Pierian, Seven Bridges, and UgenTec, and growth and โฆSee details»
Velcera - Products, Competitors, Financials, Employees, โฆ
Velcera through its FidoPharm subsidiary is a companion pet health product company committed to providing consumers with companion pet health products that contain the same active โฆSee details»
New Company, Velsera, Represents Summa Equityโs Vision to โฆ
Jan 12, 2023ย ยท Today Velsera comprises three global, industry leading organizations in the healthcare and life science industries: Pierian, Seven Bridges, and UgenTec, and growth and โฆSee details»
EW Healthcare Partners - Portfolio - Velcera, Inc.
Apr 1, 2013ย ยท Velcera was a leading companion animal health product company committed to providing consumers with best-in-class pet health products that contained the same active โฆSee details»
Velcera Company Profile 2024: Valuation, Investors, Acquisition
Provider of pet medicines in pain management, anti-allergy and parasiticides. The company provides buccal sprays for metered delivery of pharmaceutical products to animals. It provides โฆSee details»
New company, Velsera, represents Summa Equity's vision to โฆ
Jan 12, 2023ย ยท Velsera transforms science, technology, and informatics into an ecosystem of insight, making data actionable through the integration of a rich software platform, deep โฆSee details»
Perrigo Company Closes Acquisition Of Companion Animal Health โฆ
ALLEGAN, Mich., April 1, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has closed the acquisition of Velcera, Inc. ("Velcera"), Yardley, Pennsylvania โฆSee details»
Perrigo Closes Acquisition of Velcera | BioSpace
ALLEGAN, Mich., April 1, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has closed the acquisition of Velcera, Inc. ("Velcera"), Yardley, Pennsylvania โฆSee details»
Perrigo Company To Acquire OTC Companion Animal Health โฆ
Feb 1, 2013ย ยท Velcera is a leading companion pet health product company committed to providing consumers with best-in-class pet health products that contain the same active ingredients as โฆSee details»
Perrigo Closes Acquisition Of Pet Health Company Velcera
Apr 1, 2013ย ยท Perrigo Co. (Nasdaq: PRGO) Monday announced that it has closed the acquisition of Velcera Inc., the Yardley, Pa.-based pet health products company, for $160 million in cash.See details»
Clinical Communication and Workflow | Stryker
Our solutions can be tailored for your specific needs, from urgent, real-time voice communication when seconds matter, to secure messaging, closed-loop EHR workflows, and more. Unify all โฆSee details»